Table 2.
Patient characteristics
N (%) | |
Age (year, range) | 70.3 (50–85) |
Male/female | 14/6 (70/30%) |
Location | |
Head | 17 (85%) |
Body | 2 (10%) |
Body/tail | 1 (5%) |
Performance score | |
0 | 7 (35%) |
1 | 9 (45%) |
2 | 3 (15%) |
Missing | 1 (5%) |
Classification | |
Locally advanced | 18 (90%) |
Medically inoperable/ refused surgery | 2 (10%) |
Chemotherapy (after SBRT) | |
FOLFIRINOX | 2 (10%) |
Gemcitabine/nab-paclitaxel | 2 (10%) |
None | 16 (80%) |
SBRT, stereotactic body radiation therapy.